Viatris (VTRS) Change in Cash (2019 - 2026)
Viatris (VTRS) posted Change in Cash of -$915.7 million for Q2 2026, down 300.07% on a QoQ basis from $457.7 million in Q1 2026, and down 385.78% year-over-year from $320.4 million in Q2 2025.
Analysis
Viatris (VTRS) Change in Cash (2019 - 2026) Analysis & Trends
Viatris has reported Change in Cash for 8 years, with the latest figure at -$915.7 million in Q2 2026.
- On a quarterly basis, Change in Cash fell 385.78% year-over-year to -$915.7 million in Q2 2026; TTM through Jun 2026 was $322.2 million, a 191.87% increase from a year earlier, with the FY2025 full-year figure at $611.9 million, up 337.63% from the prior year.
- Change in Cash was -$915.7 million for Q2 2026 at Viatris, down from $457.7 million in the prior quarter.
- The five-year high for Change in Cash was $961.6 million in Q3 2024, with the low at -$1.1 billion in Q4 2024.
- Average Change in Cash over 5 years is $10.2 million, with a median of $21.2 million recorded in 2024.
- The largest YoY upside for Change in Cash was 3681.05% in 2023 against a maximum downside of 1568.36% in 2023.
- Over 5 years, Change in Cash stood at $612.1 million in 2022, then slumped by 151.98% to -$318.2 million in 2023, then sank by 259.52% to -$1.1 billion in 2024, then jumped by 130.11% to $344.5 million in 2025, then slumped by 365.81% to -$915.7 million in 2026.
- The last three Change in Cash figures came in at -$915.7 million (Q2 2026), $457.7 million (Q1 2026), and $344.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | -86.00 Mn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | -915.70 Mn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -44.45 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | -64.79 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 526.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 279.95 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 49.04 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 52.68 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -915.70 Mn |
| Mar 31, 2026 | 457.70 Mn |
| Dec 31, 2025 | 344.50 Mn |
| Sep 30, 2025 | 435.70 Mn |
| Jun 30, 2025 | -188.50 Mn |
| Mar 31, 2025 | 20.20 Mn |
| Dec 31, 2024 | -1.14 Bn |
| Sep 30, 2024 | 961.60 Mn |
| Jun 30, 2024 | -97.40 Mn |
| Mar 31, 2024 | 22.30 Mn |
| Dec 31, 2023 | -318.20 Mn |
| Sep 30, 2023 | 680.40 Mn |
| Jun 30, 2023 | 120.70 Mn |
| Mar 31, 2023 | -751.80 Mn |
| Dec 31, 2022 | 612.10 Mn |
| Sep 30, 2022 | -19.00 Mn |
| Jun 30, 2022 | -88.00 Mn |
| Mar 31, 2022 | 51.20 Mn |
| Dec 31, 2021 | -55.50 Mn |
| Sep 30, 2021 | 82.60 Mn |